These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23346831)

  • 21. Current issues in non-inferiority trials.
    Fleming TR
    Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rethinking statistical approaches to evaluating drug safety.
    Liu JP
    Yonsei Med J; 2007 Dec; 48(6):895-900. PubMed ID: 18159580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primer: measuring the effects of treatment in clinical trials.
    Ward MM
    Nat Clin Pract Rheumatol; 2007 May; 3(5):291-7. PubMed ID: 17471248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo--efficacy and adverse effects in controlled clinical trials.
    Weihrauch TR; Gauler TC
    Arzneimittelforschung; 1999 May; 49(5):385-93. PubMed ID: 10367099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [How to prevent hazards and to reduce risk in clinical trials?].
    Czarkowski M
    Pol Merkur Lekarski; 2008 Dec; 25(150):534-8. PubMed ID: 19205390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, operation, and interpretation of clinical trials.
    Pihlstrom BL; Barnett ML
    J Dent Res; 2010 Aug; 89(8):759-72. PubMed ID: 20581353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The credibility of the FDA.
    Blankfield RP
    Eur J Prev Cardiol; 2013 Dec; 20(6):992-4. PubMed ID: 23867140
    [No Abstract]   [Full Text] [Related]  

  • 31. Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta-analysis of randomized controlled trials.
    Schnabel A; Meyer-Frießem CH; Reichl SU; Zahn PK; Pogatzki-Zahn EM
    Pain; 2013 Jul; 154(7):1140-9. PubMed ID: 23706726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions.
    Mayne TJ; Whalen E; Vu A
    J Clin Epidemiol; 2006 Mar; 59(3):217-23. PubMed ID: 16488351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of drug toxicity in clinical trials.
    Splawinski J; Kuzniar J; Filipiak K; Zielinski W
    Sci Eng Ethics; 2006 Jan; 12(1):139-45. PubMed ID: 16501655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common pitfalls in statistical analysis: Absolute risk reduction, relative risk reduction, and number needed to treat.
    Ranganathan P; Pramesh CS; Aggarwal R
    Perspect Clin Res; 2016; 7(1):51-3. PubMed ID: 26952180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Number needed to treat in time-to-event studies].
    López-Briz E; Martínez-López I; Puigventós Latorre F; Fraga Fuentes MD;
    Med Clin (Barc); 2014 Nov; 143(10):472-3. PubMed ID: 24636018
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical perspective on risk stratification.
    Sleight P
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2516-9. PubMed ID: 9358498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The precautionary principle should not be used as a basis for decision-making. Talking point on the precautionary principle.
    Peterson M
    EMBO Rep; 2007 Apr; 8(4):305-8. PubMed ID: 17401402
    [No Abstract]   [Full Text] [Related]  

  • 38. [Risk management--adverse effects of pharmaceutical products. Interpretation of the drug package inserts].
    Mochizuki M
    Nihon Jibiinkoka Gakkai Kaiho; 2005 Aug; 108(8):814-7. PubMed ID: 16267911
    [No Abstract]   [Full Text] [Related]  

  • 39. Number needed to treat: a useful statistic to evaluate the impact of an intervention.
    Perez-Padilla R; Patino CM; Ferreira JC
    J Bras Pneumol; 2019 Dec; 45(6):e20190371. PubMed ID: 31826107
    [No Abstract]   [Full Text] [Related]  

  • 40. Biological interpretation of relative risk.
    Lanes SF
    Drug Saf; 1999 Aug; 21(2):75-9. PubMed ID: 10456376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.